NMN and NAD+ Supplements: Do They Work, and Are They Legal in the UK?

What does NMN claim to do?

NAD+ (nicotinamide adenine dinucleotide) is a molecule found in every cell. It helps turn food into usable energy and is used by enzymes that repair DNA. In animals, NAD+ levels fall with age, and raising them in old mice improves several markers of health. That research, much of it from respected labs, launched a market for "NAD+ boosters".

Sellers and longevity influencers say NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), both forms of vitamin B3 that the body turns into NAD+, can:

• slow or reverse ageing
• boost energy and stamina
• improve metabolism and blood sugar control
• protect muscle as you age
• support brain health
• improve skin and hair

These are fair summaries of what is claimed online. Here is how they stand up in people.

What does the evidence show?

Metabolism and blood sugar

The most cited human study gave 25 postmenopausal women with prediabetes 250mg of NMN a day for ten weeks. Muscle insulin sensitivity improved (how well muscle responds to insulin), but many other measures did not change. It was a small, well-run study, and several authors hold NMN-related patents.

The bigger picture comes from a 2026 meta-analysis of 15 trials using 250 to 2,000mg a day for two weeks to six months. NMN did not change body weight, BMI, fasting glucose, HbA1c (a three-month blood sugar measure), cholesterol or systolic blood pressure. Diastolic blood pressure fell slightly, and insulin resistance showed a non-significant downward trend. The authors called these "preliminary signals".

Muscle and physical function

Muscle is one of the main reasons older people try NAD+ boosters. A 2025 meta-analysis of trials in adults with an average age over 60 found NMN had no significant effect on muscle mass, grip strength, walking speed or chair-stand times. The authors concluded current evidence does not support NMN or NR for preserving muscle.

Brain health

NR has been tested in Parkinson's disease because NAD+ is linked to how brain cells produce energy. In the largest trial so far, NOPARK, 393 people with early Parkinson's took NR or placebo for a year. NR did not help; motor scores and non-motor symptoms worsened slightly more with NR than with placebo. Serious adverse events were not more common with NR. This does not show NR is harmful for healthy people, but it is a reminder that raising NAD+ does not automatically help.

Ageing and lifespan

No human trial has measured lifespan or validated "biological age" with NMN. Blood NAD+ is a lab marker, not a health outcome.

Is NMN legal in the UK?

In Great Britain, a food or supplement ingredient that was not widely eaten before May 1997 is a novel food and needs authorisation before it can be sold (see the FSA's novel foods guidance). When we searched the FSA's register of authorised novel foods in October 2026 (last updated 31 March 2026), NMN returned no results. By contrast, nicotinamide riboside chloride is authorised (NOVEL-96).

In the EU, NMN is also a novel food. In May 2026 the European Food Safety Authority published an opinion that one beta-NMN ingredient is safe at up to 300mg a day for adults, excluding pregnant and breastfeeding women. An EFSA opinion is a step towards EU authorisation, not authorisation itself, and it does not apply in Great Britain, which has its own process. In the US, the FDA reversed its earlier position in December 2025 and now allows NMN in dietary supplements.

So NMN is widely available from UK websites and some high-street retailers, but we could not find it on the GB authorised list. That matters for buyers because unauthorised products sit outside the normal checks on ingredient specification and purity. For that reason we do not feature any NMN products.

Who might reasonably try an NAD+ booster?

If you are a healthy adult who wants to experiment and understands the evidence is early, NR is the more defensible choice because it is authorised in Great Britain and has more human safety data. Think of it as a personal experiment, set a time limit (for example three months), and decide in advance what would count as a benefit.

Who should be careful?

• Pregnant or breastfeeding women: the EFSA safety opinion specifically excludes you.
• People with Parkinson's disease: given the NOPARK result, do not take NR or NMN without your neurologist's input.
• People with cancer or a history of it: NAD+ supports cell growth and repair in general, and its effect on tumours is not understood; ask your oncology team.
• People on diabetes medicines: any effect on insulin sensitivity could, in theory, change your needs; tell your GP.
• Anyone tempted by IV NAD+ drips: these are medicines given in clinics, with very little published evidence in healthy people.

If you want to try it: what to look for

• Check the legal status of the ingredient. In Great Britain that means NR (nicotinamide riboside chloride), which is on the FSA register.
• Keep to modest doses. Most human data are at 250 to 1,000mg a day for NMN and 300 to 1,000mg for NR.
• Look for a named, independently tested ingredient and a certificate of analysis from an outside lab.
• Avoid "NAD+" capsules. NAD+ itself is poorly absorbed by mouth.
• Be wary of stacks that combine NMN with resveratrol, TMG or other ingredients, which make it impossible to tell what is doing what.
• Price check: you are paying a premium for an ingredient with little proven benefit.

Bottom line

NMN and NR do roughly what they say at a chemical level: they raise NAD+-related markers in your blood. What they have not done, in trials so far, is make people measurably healthier, stronger or younger. Short-term use looks well tolerated. In Great Britain, NMN is not on the authorised novel food list, so we do not recommend any NMN products; NR is legal but its evidence is no stronger. Proven basics such as exercise, sleep and a good diet remain a far better use of your money.